5-HT 6/5-HT 2A dual antagonist (AMRI)

N/A

Report date: 2025/01/26 18:56:45
NME

Base Information

Drug Name5-HT 6/5-HT 2A dual antagonist (AMRI)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsCognition DisordersSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlbany Molecular Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlbany Molecular Research Inc
Inactive CompaniesN/A
Active IndicationsCognition DisordersSleep Wake Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A